Literature DB >> 17143303

Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro.

S Vandevoorde1, K-O Jonsson, G Labar, E Persson, D M Lambert, C J Fowler.   

Abstract

BACKGROUND AND
PURPOSE: Two compounds, URB602 and URB754, have been reported in the literature to be selective inhibitors of monoacylglycerol lipase, although a recent study has questioned their ability to prevent 2-arachidonoyl hydrolysis by brain homogenates and cerebellar membranes. In the present study, the ability of these compounds to inhibit monoacylglycerol lipase and fatty acid amide hydrolase has been reinvestigated. EXPERIMENTAL APPROACH: Homogenates and cell lines were incubated with test compounds and, thereafter, with either [(3)H]-2-oleoylglycerol or [(3)H]-anandamide. Labelled reaction products were separated from substrate using chloroform: methanol extraction. KEY
RESULTS: In cytosolic fractions from rat brain, URB602 and URB754 inhibited the hydrolysis of 2-oleoylglycerol with IC(50) values of 25 and 48 microM, respectively. Anandamide hydrolysis by brain membranes was not sensitive to URB754, but was inhibited by URB602 (IC(50) value 17 microM). Hydrolysis of 2-oleoylglycerol by human recombinant monoacylglycerol lipase was sensitive to URB602, but not URB754. The lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis was also observed for intact RBL2H3 basophilic leukaemia cells. C6 glioma expressed mRNA for monoacylglycerol lipase, and hydrolyzed 2-oleoylglycerol in a manner sensitive to inhibition by methyl arachidonoyl fluorophosphonate but not URB754 or URB597. MC3T3-E1 mouse osteoblastic cells, which did not express mRNA for monoacylglycerol lipase, hydrolyzed 2-oleoylglycerol in the presence of URB597, but the hydrolysis was less sensitive to methyl arachidonoyl fluorophosphonate than for C6 cells. CONCLUSIONS AND IMPLICATIONS: The data demonstrate that the compounds URB602 and URB754 do not behave as selective and/or potent inhibitors of monoacylglycerol lipase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143303      PMCID: PMC2042901          DOI: 10.1038/sj.bjp.0706971

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Modulation of anxiety through blockade of anandamide hydrolysis.

Authors:  Satish Kathuria; Silvana Gaetani; Darren Fegley; Fernando Valiño; Andrea Duranti; Andrea Tontini; Marco Mor; Giorgio Tarzia; Giovanna La Rana; Antonio Calignano; Arcangela Giustino; Maria Tattoli; Maura Palmery; Vincenzo Cuomo; Daniele Piomelli
Journal:  Nat Med       Date:  2002-12-02       Impact factor: 53.440

2.  Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus.

Authors:  Judit K Makara; Marco Mor; Darren Fegley; Szilárd I Szabó; Satish Kathuria; Giuseppe Astarita; Andrea Duranti; Andrea Tontini; Giorgio Tarzia; Silvia Rivara; Tamás F Freund; Daniele Piomelli
Journal:  Nat Neurosci       Date:  2005-08-07       Impact factor: 24.884

3.  Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue.

Authors:  H Tornqvist; P Belfrage
Journal:  J Biol Chem       Date:  1976-02-10       Impact factor: 5.157

4.  Lowry protein assay containing sodium dodecyl sulfate in microtiter plates for protein determinations on fractions from brain tissue.

Authors:  C R Harrington
Journal:  Anal Biochem       Date:  1990-05-01       Impact factor: 3.365

5.  Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase.

Authors:  Séverine Vandevoorde; Bijali Saha; Anu Mahadevan; Raj K Razdan; Roger G Pertwee; Billy R Martin; Christopher J Fowler
Journal:  Biochem Biophys Res Commun       Date:  2005-11-11       Impact factor: 3.575

6.  Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand.

Authors:  S K Goparaju; N Ueda; H Yamaguchi; S Yamamoto
Journal:  FEBS Lett       Date:  1998-01-23       Impact factor: 4.124

7.  An endocannabinoid mechanism for stress-induced analgesia.

Authors:  Andrea G Hohmann; Richard L Suplita; Nathan M Bolton; Mark H Neely; Darren Fegley; Regina Mangieri; Jocelyn F Krey; J Michael Walker; Philip V Holmes; Jonathon D Crystal; Andrea Duranti; Andrea Tontini; Marco Mor; Giorgio Tarzia; Daniele Piomelli
Journal:  Nature       Date:  2005-06-23       Impact factor: 49.962

8.  RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol.

Authors:  Thien P Dinh; Satish Kathuria; Daniele Piomelli
Journal:  Mol Pharmacol       Date:  2004-07-22       Impact factor: 4.436

9.  Swiss 3T3 cells preferentially incorporate sn-2-arachidonoyl monoacylglycerol into sn-1-stearoyl-2-arachidonoyl phosphatidylinositol.

Authors:  C M Simpson; H Itabe; C N Reynolds; W C King; J A Glomset
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

10.  A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase.

Authors:  Linda Boldrup; Sandy J Wilson; Ann J Barbier; Christopher J Fowler
Journal:  J Biochem Biophys Methods       Date:  2004-08-31
View more
  32 in total

Review 1.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

2.  Microglia produce and hydrolyze palmitoylethanolamide.

Authors:  Giulio G Muccioli; Nephi Stella
Journal:  Neuropharmacology       Date:  2007-06-02       Impact factor: 5.250

3.  Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling.

Authors:  Bin Pan; Wei Wang; Jonathan Z Long; Dalong Sun; Cecilia J Hillard; Benjamin F Cravatt; Qing-song Liu
Journal:  J Pharmacol Exp Ther       Date:  2009-08-07       Impact factor: 4.030

Review 4.  Enzymatic pathways that regulate endocannabinoid signaling in the nervous system.

Authors:  Kay Ahn; Michele K McKinney; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2008-04-23       Impact factor: 60.622

Review 5.  Monoacylglycerol lipase - a target for drug development?

Authors:  C J Fowler
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

6.  Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice.

Authors:  Bogna Ignatowska-Jankowska; Jenny L Wilkerson; Mohammed Mustafa; Rehab Abdullah; Micah Niphakis; Jenny L Wiley; Benjamin F Cravatt; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2015-03-11       Impact factor: 4.030

7.  A novel monoacylglycerol lipase inhibitor with analgesic and anti-inflammatory activity.

Authors:  Victoria Magrioti; George Naxakis; Dimitra Hadjipavlou-Litina; Alexandros Makriyannis; George Kokotos
Journal:  Bioorg Med Chem Lett       Date:  2008-09-12       Impact factor: 2.823

Review 8.  The pharmacology of the cannabinoid system--a question of efficacy and selectivity.

Authors:  Christopher J Fowler
Journal:  Mol Neurobiol       Date:  2007-07-07       Impact factor: 5.590

9.  Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.

Authors:  Jonathan Z Long; Weiwei Li; Lamont Booker; James J Burston; Steven G Kinsey; Joel E Schlosburg; Franciso J Pavón; Antonia M Serrano; Dana E Selley; Loren H Parsons; Aron H Lichtman; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2008-11-23       Impact factor: 15.040

Review 10.  Dynamic regulation of the endocannabinoid system: implications for analgesia.

Authors:  Devi Rani Sagar; A Gemma Gaw; Bright N Okine; Stephen G Woodhams; Amy Wong; David A Kendall; Victoria Chapman
Journal:  Mol Pain       Date:  2009-10-08       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.